TXG
10x Genomics Inc.
$24.62
+$0.94(+3.97%)
65
Overall
40
Value
90
Tech
65
Quality
Market Cap
$1.62B
Volume
1.97M
52W Range
$8.31 - $26.45
Target Price
$24.85
Order:
Income Statement
| Metric | Trend | Chart | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Total Revenue | $245.9M | $298.8M | $490.5M | $516.4M | $618.7M | $610.8M | $642.8M | ||
| Total Revenue | $245.9M | $298.8M | $490.5M | $516.4M | $618.7M | $610.8M | $642.8M | ||
| COST OF GOODS SOLD | |||||||||
| Cost of Revenue | $61.0M | $58.5M | $74.1M | $120.4M | $209.4M | $196.3M | $198.9M | ||
| GROSS PROFIT | |||||||||
| Gross Profit | $184.9M | $240.4M | $416.4M | $396.0M | $409.3M | $414.5M | $443.9M | ||
| OPERATING EXPENSES | |||||||||
| Operating Expenses | $215.4M | $774.5M | $468.7M | $564.0M | $674.6M | $609.0M | $504.9M | ||
| Research & Development | $83.1M | $570.9M | $211.8M | $265.7M | $270.3M | $264.7M | $238.6M | ||
| Research Expense | $83.1M | $570.9M | $211.8M | $265.7M | $270.3M | $264.7M | $238.6M | ||
| Selling, General & Administrative | $130.8M | $202.3M | $331.7M | $298.3M | $343.3M | $344.3M | $316.1M | ||
| Selling & Marketing Expenses | $1.5M | $1.9M | $4.7M | $3.7M | $3.3M | $3.9M | -- | ||
| General & Administrative Expenses | $130.8M | $202.3M | $331.7M | $298.3M | $343.3M | $344.3M | $316.1M | ||
| Promotion & Advertising | $1.5M | $1.9M | $4.7M | -- | -- | -- | -- | ||
| Depreciation & Amortization | $61.0M | $12.3M | $18.5M | $22.8M | $32.9M | $33.9M | -- | ||
| Depreciation & Amortization | $61.0M | $12.3M | $18.5M | -- | -- | -- | -- | ||
| Amortization | $61.0M | $1.8M | $4.5M | $4.5M | $4.5M | $1.6M | -- | ||
| Other Operating Expenses | $-2.2M | $-8.6M | $-9.4M | -- | -- | -- | -- | ||
| OPERATING INCOME | |||||||||
| Operating income | $-30.6M | $-534.1M | $-52.3M | $-167.9M | $-265.3M | $-194.6M | $-61.0M | ||
| EBITDA | $-20.8M | $-513.8M | $-24.6M | $-128.5M | $-205.1M | $-134.0M | $3.9M | ||
| NON-OPERATING ITEMS | |||||||||
| Interest Expense (Non-Operating) | $3.1M | $1.7M | $866.0K | $476.0K | $33.0K | $4.0K | -- | ||
| Intinc | $2.8M | $1.5M | $206.0K | $6.6M | $16.9M | $18.9M | $69.9M | ||
| Net Non-Operating Interest Income/Expense | $-274.0K | $-150.0K | $-660.0K | $6.2M | $16.9M | $18.9M | $69.9M | ||
| Other Income/Expense | $186.0K | $184.0K | $802.0K | $-198.0K | $307.0K | $2.1M | $-1.0M | ||
| Other Special Charges | $-186.0K | $-184.0K | $-802.0K | $-198.0K | $-307.0K | $-2.1M | $1.0M | ||
| SPECIAL ITEMS | |||||||||
| Special Income Charges | $-61.0M | -- | -- | $-4.2M | $-2.5M | $-259.0K | -- | ||
| PRE-TAX INCOME | |||||||||
| EBIT | $-28.0M | $-474.3M | $-52.8M | $-161.5M | $-248.7M | $-177.7M | $-39.9M | ||
| Pre-Tax Income | $-31.0M | $-534.5M | $-53.7M | $-162.0M | $-248.8M | $-177.7M | $-39.9M | ||
| INCOME TAX | |||||||||
| Tax Provision | $218.0K | $8.3M | $4.5M | $4.0M | $6.3M | $4.9M | $3.6M | ||
| NET INCOME | |||||||||
| Net Income | $-31.3M | $-542.7M | $-58.2M | $-166.0M | $-255.1M | $-182.6M | $-43.5M | ||
| Net Income (Continuing Operations) | $-31.3M | $-542.7M | $-58.2M | $-166.0M | $-255.1M | $-182.6M | $-43.5M | ||
| Net Income (Discontinued Operations) | $-31.3M | $-542.7M | $-58.2M | $-166.0M | $-255.1M | $-182.6M | $-43.5M | ||
| Net Income (Common Stockholders) | $-31.3M | $-542.7M | $-58.2M | $-166.0M | $-255.1M | $-182.6M | $-43.5M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | $-39.5M | ||
| TOTALS | |||||||||
| Total Expenses | $276.5M | $833.0M | $542.7M | $684.4M | $884.1M | $805.3M | $703.8M | ||
| SHARE & EPS DATA | |||||||||
| Average Shares Outstanding | $39.1M | $101.2M | $110.3M | $113.9M | $117.2M | $120.5M | $124.7M | ||
| Average Shares Outstanding (Diluted) | $39.1M | $101.2M | $110.3M | $113.9M | $117.2M | $120.5M | $124.7M | ||
| Shares Outstanding | $96.6M | $108.8M | $116.9M | $115.4M | $119.2M | $122.3M | $127.8M | ||
| Basic EPS | $-0.80 | $-5.37 | $-0.53 | $-1.46 | $-2.18 | $-1.52 | $-0.35 | ||
| Basic EPS (Continuing Operations) | $-0.80 | $-5.37 | $-0.53 | $-1.46 | $-2.18 | $-1.52 | $-0.35 | ||
| Diluted EPS | $-0.80 | $-5.37 | $-0.53 | $-1.46 | $-2.18 | $-1.52 | $-0.35 | ||
| Diluted EPS (Continuing Operations) | -- | -- | $-0.53 | $-1.46 | $-2.18 | $-1.52 | $-0.35 | ||
| OTHER METRICS | |||||||||
| Interest Expense Operating | -- | $58.5M | -- | -- | -- | -- | -- | ||
| Loss And Loss Adjustment Expected Incurred | $1.5M | $1.3M | $-660.0K | -- | -- | -- | -- | ||
| Non Recurring Operation Expense | $61.0M | -- | -- | -- | -- | -- | -- | ||
| Other Gand A | $130.8M | $202.3M | $331.7M | $298.3M | $343.3M | $344.3M | $316.1M | ||
| Rent And Landing Fees | $6.8M | -- | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TXG | $24.62 | +4.0% | 1.97M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |